PHILADELPHIA, March 8, 2016 /PRNewswire/ --
Provides daily updated drug information to ensure patient safety; optional cloud delivery for a more versatile, forward-thinking drug database
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that it is now offering its Gold Standard Drug Database (GSDD) Application Program Interface (API) in the Elsevier cloud powered by Amazon Web Services. This new optional delivery method will make it easier for clients to receive and integrate data feeds, thereby saving time and resources, people and hardware.
Benefits of the web-accessible, cloud-hosted GSDD solution suite include:
- Integrates easily with existing technology without significant cost
- Provides faster updates
- Eliminates hardware storage and physical maintenance costs
- Improves data safety
- Enables robust disaster recovery capabilities.
Karthik Krishnan, Senior Vice President, Clinical Reference & Workflow, Elsevier Clinical Solutions, said that offering the GSDD database in the Elsevier cloud provides significant benefits to the client, including the flexibility to connect (API) with existing business systems.
“With less time needed to focus on technology and more time available to run their business, clients will be able to take advantage of the daily updates,” Krishnan said. “And the new API can significantly improve business ROI.”
The new cloud-hosted web API joins Elsevier’s existing GSDD delivery options in technological superiority among drug databases. Features unique to GSDD include:
- TRUE Daily Updates™ - Every day, including weekends and holidays, Elsevier updates its drug information - such as clinical and patient safety data, drug pricing and images - for all content. When a new drug launches or an important change is announced, customers can access all pertinent information that same day to avoid dispensing delays and potential risks to patient safety. Only Elsevier offers TRUE Daily Updates™.
- Patient Safeguards - Drug information changes every day. Sometimes, these changes have major implications for patient safety since clinical information that lags behind for weeks could lead to uninformed decisions and serious errors at the point of care. To address this issue, Elsevier publishes clinical updates daily (including on weekends), averaging more than 80 updates/day throughout the year.
- Superior Technology - Other drug databases utilize older technology that necessitates delayed updates and laborious processing. Elsevier utilizes the latest technology, enabling customers to update easily and automatically on their own schedules; those that leverage the cloud API won’t need to manage or initiate updates at all.
- Adaptation for Industry Needs - GSDD is the only drug database built on a relational framework that integrates quickly with no mapping and low maintenance. When industry changes require adaptations, Elsevier simply updates its single database, eliminating file mapping and implementation burdens for customers.
“With this new offering, Elsevier is responding to a market need for customers who no longer want to focus their efforts on making technology work and shift their focus to driving their pharmacy business forward. The APIs provide the customers an opportunity to easily integrate with other business systems and scale their workflow in ways not possible for,” added Krishnan.
Elsevier’s GSDD is the next-generation drug database and drug decision support engine, fulfilling complex and evolving drug information needs throughout the healthcare system. GSDD enables healthcare professionals to quickly make fully informed decisions on drug prescribing, dispensing, adjudication and analysis. GSDD delivers the most current, accurate and relevant drug data with TRUE Daily Updates™, eliminating alert fatigue and delivering appropriate answers according to the healthcare setting. For additional information, visit http://www.goldstandard.com.
About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey - and publishes over 2,500 journals, including The Lancet and Cell, and more than 33,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. http://www.elsevier.com
Media contact
Christopher Capot
Director, Corporate Relations
Elsevier
+1-917-704-5174
